Phase IA Clinical Trial Evaluating the Tolerability, Pharmacokinetics, and Analgesic Efficacy of an Intrathecally Administered Neurotensin A Analogue in Central Neuropathic Pain Following Spinal Cord Injury. [electronic resource]
Producer: 20180123Description: 250-8 p. digitalISSN:- 2160-7648
- Analgesics -- administration & dosage
- Dose-Response Relationship, Drug
- Glycoproteins -- administration & dosage
- Humans
- Injections, Spinal
- Maximum Tolerated Dose
- Models, Biological
- Neuralgia -- drug therapy
- Neuropeptides -- administration & dosage
- Neurotensin -- analogs & derivatives
- Spinal Cord Injuries -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.